Peters S - Search Results

1

Beyond Chemoimmunotherapy in Advanced Non-Small Cell Lung Cancer: New Frontiers, New Challenges.

Mountzios G, Naidoo J, Wang C, Creelan BC, Trotier DC, Campbell TC, Peters S. Mountzios G, et al. Among authors: peters s. Am Soc Clin Oncol Educ Book. 2024 Jun;44(3):e432526. doi: 10.1200/EDBK_432526. Am Soc Clin Oncol Educ Book. 2024. PMID: 38781566 Free article. Review.

2

2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

Eberhardt WE, De Ruysscher D, Weder W, Le Péchoux C, De Leyn P, Hoffmann H, Westeel V, Stahel R, Felip E, Peters S; Panel Members. Eberhardt WE, et al. Among authors: peters s. Ann Oncol. 2015 Aug;26(8):1573-88. doi: 10.1093/annonc/mdv187. Epub 2015 Apr 20. Ann Oncol. 2015. PMID: 25897013 Free article. Review.

3

Immunotherapy in the first-line treatment of elderly patients with advanced non-small-cell lung cancer: results of an International Experts Panel Meeting by the Italian Association of Thoracic Oncology (AIOT).

Gridelli C, Peters S, Velcheti V, Attili I, de Marinis F. Gridelli C, et al. Among authors: peters s. ESMO Open. 2023 Apr;8(2):101192. doi: 10.1016/j.esmoop.2023.101192. Epub 2023 Mar 23. ESMO Open. 2023. PMID: 36965261 Free PMC article. Review.

4

Adjuvant Treatments for Surgically Resected Non-Small Cell Lung Cancer Harboring EGFR Mutations: A Review.

Passaro A, Mok TSK, Attili I, Wu YL, Tsuboi M, de Marinis F, Peters S. Passaro A, et al. Among authors: peters s. JAMA Oncol. 2023 Aug 1;9(8):1124-1131. doi: 10.1001/jamaoncol.2023.0459. JAMA Oncol. 2023. PMID: 37166792 Review.

5

Immune-checkpoint inhibition for resectable non-small-cell lung cancer - opportunities and challenges.

Mountzios G, Remon J, Hendriks LEL, García-Campelo R, Rolfo C, Van Schil P, Forde PM, Besse B, Subbiah V, Reck M, Soria JC, Peters S. Mountzios G, et al. Among authors: peters s. Nat Rev Clin Oncol. 2023 Oct;20(10):664-677. doi: 10.1038/s41571-023-00794-7. Epub 2023 Jul 24. Nat Rev Clin Oncol. 2023. PMID: 37488229 Review.

6

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.

Borghaei H, de Marinis F, Dumoulin D, Reynolds C, Theelen WSME, Percent I, Gutierrez Calderon V, Johnson ML, Madroszyk-Flandin A, Garon EB, He K, Planchard D, Reck M, Popat S, Herbst RS, Leal TA, Shazer RL, Yan X, Harrigan R, Peters S; SAPPHIRE Investigators. Borghaei H, et al. Among authors: peters s. Ann Oncol. 2024 Jan;35(1):66-76. doi: 10.1016/j.annonc.2023.10.004. Epub 2023 Oct 20. Ann Oncol. 2024. PMID: 37866811 Clinical Trial.

7

Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.

Passaro A, Al Bakir M, Hamilton EG, Diehn M, André F, Roy-Chowdhuri S, Mountzios G, Wistuba II, Swanton C, Peters S. Passaro A, et al. Among authors: peters s. Cell. 2024 Mar 28;187(7):1617-1635. doi: 10.1016/j.cell.2024.02.041. Cell. 2024. PMID: 38552610 Free PMC article. Review.

8

Searching for targets for the systemic therapy of mesothelioma.

Stahel RA, Weder W, Felley-Bosco E, Petrausch U, Curioni-Fontecedro A, Schmitt-Opitz I, Peters S. Stahel RA, et al. Among authors: peters s. Ann Oncol. 2015 Aug;26(8):1649-60. doi: 10.1093/annonc/mdv101. Epub 2015 Feb 26. Ann Oncol. 2015. PMID: 25722383 Free article. Review.

9

Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohort.

Mazières J, Barlesi F, Filleron T, Besse B, Monnet I, Beau-Faller M, Peters S, Dansin E, Früh M, Pless M, Rosell R, Wislez M, Fournel P, Westeel V, Cappuzzo F, Cortot A, Moro-Sibilot D, Milia J, Gautschi O. Mazières J, et al. Among authors: peters s. Ann Oncol. 2016 Feb;27(2):281-6. doi: 10.1093/annonc/mdv573. Epub 2015 Nov 23. Ann Oncol. 2016. PMID: 26598547 Free article.

10

Preoperative chemoradiotherapy with cisplatin and docetaxel for stage IIIB non-small-cell lung cancer: 10-year follow-up of the SAKK 16/01 trial.

Früh M, Ris HB, Xyrafas A, Peters S, Mirimanoff RO, Gautschi O, Pless M, Stupp R. Früh M, et al. Among authors: peters s. Ann Oncol. 2016 Oct;27(10):1971-3. doi: 10.1093/annonc/mdw251. Epub 2016 Jun 29. Ann Oncol. 2016. PMID: 27358380 Free article. Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,751 results

Search Page

Filters